Bruno Oesch

Founder at Neurotune AG

Health Technology

Consumer Services

Profile

Bruno Oesch is the founder.
He founded Prionics AG in 1997 and served as the Co-Chief Executive Officer in 2011.
He also founded Neurotune AG in 2005 and currently serves as the Chairman.
Additionally, he founded Malcisbo AG in 2010 and currently holds the position of Chief Executive Officer & Director.
Dr. Oesch's former job was as a Principal at The University of California, San Francisco.
He obtained a doctorate degree from the University of Zurich and a graduate degree from the Swiss Federal Institute of Technology.

Bruno Oesch active positions

Companies	Position	Start
Neurotune AG Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland.	Founder	31/12/2004
Malcisbo AG Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland.	Founder	30/04/2010

All active positions of Bruno Oesch

Former positions of Bruno Oesch

Companies	Position	End
The University of California, San Francisco	Corporate Officer/Principal	-
Prionics AG Prionics AG Medical SpecialtiesHealth Technology Prionics AG engages in the research in as well as the development, production, and distribution of diagnostic solutions for farm animal diseases. It focuses on diseases that can be transmitted from animals to human beings such as mad cow's disease and other prion diseases. The company was founded by Bruno Oesch and Markus Moser on February 27, 1997 and is headquartered in Schlieren, Switzerland.	Founder	-

See the detail of Bruno Oesch's experience

Training of Bruno Oesch

Swiss Federal Institute of Technology	Graduate Degree
University of Zurich	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bruno Oesch's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Neurotune AG Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland.	Health Technology
Prionics AG Prionics AG Medical SpecialtiesHealth Technology Prionics AG engages in the research in as well as the development, production, and distribution of diagnostic solutions for farm animal diseases. It focuses on diseases that can be transmitted from animals to human beings such as mad cow's disease and other prion diseases. The company was founded by Bruno Oesch and Markus Moser on February 27, 1997 and is headquartered in Schlieren, Switzerland.	Health Technology
Malcisbo AG Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland.	Health Technology

See company connections